TNXPTonix Pharmaceuticals Holding Corp.

CSNasdaq (XNAS)·USD

Identity

Security key: 22635
Ticker: TNXP
Type: CS — Common Stock
Exchange: Nasdaq(XNAS)
Venue group: NASDAQ
Operating MIC: XNAS
Market: stocks
Locale: us
Currency: USD
Listed: 2009-02-13
Round lot: 100
Active: Yes
Last seen in a load: 2026-08-14 20:49
Vendor updated: 2026-08-13 06:09
Ticker root / suffix: TNXP

Detail

Enriched 2026-08-14 20:47

Market cap: $205,297,757.28
Shares outstanding (class): 15,940,801
Shares outstanding (weighted): 17,151,024
SIC: 2834 PHARMACEUTICAL PREPARATIONS
Employees: 142
Location: BERKELEY HEIGHTS, NJ
Homepage: https://www.tonixpharma.com
Description: Tonix Pharmaceuticals Holding Corp is a fully-integrated biopharmaceutical company commercializing and developing therapies for central nervous system (CNS) disorders, immunology, infectious diseases, and rare diseases. Its portfolio consists of commercial, development and discovery-stage programs, TONMYA, an approved treatment for fibromyalgia, as well as marketed acute migraine products Zembrace SymTouch and Tosymra. The company is conducting clinical trials to evaluate TONMYA for additional indications such as depressive disorder and acute stress disorder. It is also advancing a pipeline of immunology programs, including monoclonal antibody TNX-4800 for Lyme disease prophylaxis and TNX-1500, a third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection.

Market cap and share counts drift.

Funds holding this security

51 funds · 51 positions · $15.75M reported value, as of 2026-03-31

All holders →

Fund	Ticker	Position value	% of fund	Balance	Match
VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS	VTI	$4.95M	0.00%	359,728 NS	FIGI
iShares Russell 2000 ETF iShares Trust	IWM	$4.54M	0.01%	329,832 NS	FIGI
VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS	VXF	$2.02M	0.00%	146,955 NS	FIGI
iShares Russell 2000 Value ETF iShares Trust	IWN	$1.60M	0.01%	116,280 NS	FIGI
iShares Micro-Cap ETF iShares Trust	IWC	$470.4K	0.04%	34,213 NS	FIGI
Master Small Cap Index Series Quantitative Master Series LLC	—	$270.5K	0.01%	19,672 NS	FIGI
iShares Core S&P Total U.S. Stock Market ETF iShares Trust	ITOT	$240.0K	0.00%	17,453 NS	FIGI
Fidelity Small Cap Value Index Fund Fidelity Salem Street Trust	—	$230.4K	0.01%	16,760 NS	FIGI
EQ/2000 Managed Volatility Portfolio EQ Advisors Trust	—	$168.3K	0.00%	12,239 NS	FIGI
VANGUARD BALANCED INDEX FUND VANGUARD VALLEY FORGE FUNDS	—	$107.3K	0.00%	7,807 NS	FIGI
EQ/Small Company Index Portfolio EQ Advisors Trust	—	$106.0K	0.01%	7,710 NS	FIGI
LVIP SSGA Small-Cap Index Fund LINCOLN VARIABLE INSURANCE PRODUCTS TRUST	—	$104.5K	0.01%	7,600 NS	FIGI
Small Cap Index Fund Northern Funds	—	$98.3K	0.01%	7,147 NS	FIGI
Bridge Builder Small/Mid Cap Value Fund Bridge Builder Trust	—	$90.6K	0.00%	6,590 NS	FIGI
T. Rowe Price Extended Equity Market Index Fund T. ROWE PRICE INDEX TRUST, INC.	—	$74.3K	0.01%	5,400 NS	FIGI

How positions resolve to the securities master. FIGI_COMPOSITE is exact identifier equality — both sides got the FIGI from Bloomberg. TICKER is a narrow fallback used only where the master row carries no FIGI at all (2,389 rows do not, disproportionately Irish-domiciled US listings like LIN and ACN). Roughly 22% of all positions resolve to the master.

Funds holding this security

Identifiers

master.security_identifier

TICKERTNXP
FIGI_COMPOSITEBBG000LG8XM5
FIGI_SHARE_CLASSBBG001T49NZ9
CIK0001430306
ISINUS8902608392
Resolved through OpenFIGI from a holdings ISIN, not supplied by the securities vendor.

Identifiers

Classification

classification.v_security_classification

Asset class: Equity
Sector: Health Care
Industry: Pharmaceuticals
Source: LLMunreviewed
Self-reported confidence: 0.95
Model: deepseek
Rationale: SIC code 2834 indicates pharmaceutical preparations, and the company is a biopharmaceutical firm.

Classifications are unreviewed model output. All 5,771 assignments carry source = LLM and is_reviewed = false. Confidence is the model’s own estimate and is not calibrated — it clustered at 0.90–0.98 across the whole first pass, including rows that later proved wrong. Use it to order a review queue, not as a probability. Two share classes of one issuer can disagree.

Classification

Fund data

Not linked to a fund series.

Either this is not a fund, or it is one the SEC share-class snapshot cannot reach — commodity trusts and notes have no series ID at all.